glp-1 obesity treatment Q&A: Long-term success of therapies hinges on more than just a prescription GLP-1 Weight Loss Specialist in

The only instructional material was a one-page card with a QR code labeled how to inject. That is thin guidance for a patient injecting for the first time, which presents a safety concern because the FDA has reported dosing errors with compounded injectable semaglutide, including some adverse events requiring hospitalization

Ipamorelin is not FDA-approved for any indication

The inclusion of patients with slightly lower ejection fractions was justified because the efficacy of SGLT2Is had been demonstrated in these patients as well, although the greatest benefit was observed in populations with higher ejection fractions

ZieniukBPawekowiczM

G.PerriE